Current Good Manufacturing Practice for Radiopharmaceutical Products (GMPR)
PDF
Cite
Share
Request
Guideline
P: 295-306
November 2020

Current Good Manufacturing Practice for Radiopharmaceutical Products (GMPR)

Nucl Med Semin 2020;6(3):295-306
1. Dokuz Eylül Üniversitesi Tıp Fakültesi, Nükleer Tıp Anabilim Dalı, İzmir, Türkiye
No information available.
No information available
PDF
Cite
Share
Request

ABSTRACT

Radiopharmaceutical products are classified as specialty medicinal products containing radionuclides whose half-lives range from a few minutes to several days, and therefore they form the basis of the same regulations as non-radioactive medicinal products. Radiopharmaceuticals should be manufactured in accordance with the basic principles of good manufacturing practice (GMP). Therefore, as complementary to the GMP general requirements for pharmaceutical products, it is particularly relevant to the production and control of radiopharmaceuticals. Due to their short half-life, many radiopharmaceuticals are placed on the market shortly after they are manufactured and administered to patients, so quality control can sometimes be retrospective. Therefore, strict adherence to GMP is imperative. These guidelines are intended to provide an overview of minimum GMP requirements for radiopharmaceuticals. The manual can also be used as training material for production, quality control and quality assurance personnel in the industry as well as inspectors.

References

1Good Manufacturing Practices for Pharmaceutical Products. In: WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-second report. Geneva, World Health Organization, Annex 2 (WHO Technical Report Series, No. 986), 2014. Available from: https://www.who.int/medicines/areas/quality_safety/quality_assurance/TRS986annex2.pdf?ua=1
2Good Manufacturing Practices for Sterile Pharmaceutical Products. In: WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-sixth report. Geneva, World Health Organization, 2011, Annex 6 (WHO Technical Report Series, No. 961). Available from: https://www.who.int/medicines/areas/quality_safety/quality_assurance/GMPSterilePharmaceuticalProductsTRS961Annex6.pdf?ua=1
3Good Manufacturing Practices: Validation - Analytical Method Validation (WHO Technical Report Series, No. 1019, Annex 3, Appendix 4, 2019). Avaialable from: http://digicollection.org/whoqapharm/documents/s23430en/s23430en.pdf
4Good Manufacturing Practices: Validation (WHO Technical Report Series, No. 1019, Annex 3, 2019). Available from: http://digicollection.org/whoqapharm/documents/s23430en/s23430en.pdf
5Good Practice for Introducing Radiopharmaceuticals for Clinical Use. Details: IAEA608 TECDOC-1782; (ISBN:978-92-0-111215-6); 2015. Available from: https://www.who.int/medicines/areas/quality_safety/quality_assurance/QAS18.782_Rev1_IAEA_WHO_gmp_for_radiopharmaceutical_products.pdf?ua=1
6Quality Assurance of Pharmaceuticals. A Compendium of Guidelines and Related Materials. Good Manufacturing Practices and Inspection. Geneva, World Health Organization, 2018. Available from: https://www.who.int/medicines/areas/quality_safety/quality_assurance/QualityAssurancePharmVol2.pdf
7ICH Harmonised Tripartite Guideline Validation of Analytical Procedures: Text and Methodology, Step 4 of the ICH Process, November:2005. Available from: https://database.ich.org/sites/default/files/Q2_R1__Guideline.pdf
8Radiation Protection and Safety in Medicinal Uses of Ionizing Radiation. Vienna. Jointly Sponsored by IAEA, ILO, PAHO, and WHO. 2018 (Specific Safety Guide No.SSG-46). Available from: https://www.iaea.org/publications/11102/radiation-protection-and-safety-in-medical-uses-of-ionizing-radiation
9Working Document QAS/18.782 JULY 2019 Draft Document For Comments 1 International Atomic Energy Agency (Iaea)/Who 2 Guidelines On Good Manufacturing Products For Radiopharmaceutical Products 4 5 (July 2019) 6 Draft For Comments. Available from: https://www.who.int/medicines/areas/quality_safety/quality_assurance/QAS18.782_Rev1_IAEA_WHO_gmp_for_radiopharmaceutical_products.pdf?ua=1
10Regulations for the Safe Transport of Radioactive Material. Vienna, International Atomic Energy Agency, 2009 (IAEA Safety Requirements Safety Standards Series, No. TS-R-1, Revised). Available from: https://www-pub.iaea.org/MTCD/publications/PDF/Pub1384_web.pdf
11Radiation Protection and Safety of Radiation Sources: International Basic Safety Standards.Vienna. Jointly Sponsored by EC, FAO, IAEA, ILO, OECD/NEA, PAHO, UNEP and WHO. 2014 (Safety Series Requirements, No. GSR Part 3). Available from: https://www-pub.iaea.org/MTCD/publications/PDF/Pub1578_web-57265295.pdf
12Validation of Analytical Procedures, PA/PH/OMCL (13) 82 2R- OMCL Network/Council of Europe, 2014. Available from: https://www.edqm.eu/sites/default/files/medias/fichiers/OMCL/Quality_Management_Documents/omcl_validation_verification_of_analytical_procedures_paphomcl1382r5.pdf
13Quality Control in the Production of Radiopharmaceuticals. Details: IAEA-TECDOC600 1856; (ISBN:978-92-0-107918-3); 2018. Available from: https://www-pub.iaea.org/MTCD/Publications/PDF/TE-1856web.pdf
Article is only available in PDF format. Show PDF
2024 ©️ Galenos Publishing House